Releases: monarch-initiative/MAxO
2024-07-29 Release
Added many new terms this release to answer the annotation needs. Also added 'route of administration' for ease of annotation.
Content changes
New terms added
Add new branch: Route of administration (topical, transdermal, enteral, intravenous, vaginal, rectal, ocular, eye drop, intravitreal, nasal, otic, parenteral, oral, buccal, sublingual)
hearing aid use with FM amplification
denture usage
dental implantation
dental bridge implantation
dopamine replacement agent therapy
percutaneous umbilical blood sampling
thoracoamniotic shunt
fetoscopic laser coagulation
myelomeningocele repair
fetoscopic tracheal occlusionon
parathyroid hormone treatment
monoamine-depleting agent therapy
manganese chelator therapy
fluid restriction recommendation
fat diet recommendation
orotracheal intubation
nasotracheal intubation
orogastric intubation
nasogastric intubation
fiberoptic intubation
topical corticosteroid therapy
eye drop-lowering therapy
canaloplasty ab externo
canaloplasty ab interno
canaloplasty with suprachoroidal drainage
mini-canaloplasty
canaloplasty without catheterization
minimally invasive glaucoma surgery
preserflo microshunt MIGS
pilocarpine therapy
topical pharmacotherapy
emollient therapy
steroid agent therapy
urea-hydrocortisone therapy
stool softener therapy
laser surgery procedure
phototherapeutic keratectomy
soft bandage contact lens close
anterior stromal puncture
alcohol delamination of corneal epithelium
corneal epithelial debridement
corneal epithelial debridement with diamond burr polishing
artificial tears therapy
sodium chloride hypertonicity ophthalmic ointment therapy
punctal occlusion
autologous serum eye drop therapy
nighttime eye ointment therapy
amniotic membrane transplantation
RNAi therapy
antisense oligonucleotide inhibitor therapy
patient reproductive history
age at menarch assessment
age at menopause assessment
tubal ligation
removal of cyst
removal of ovarian cyst
removal of kidney cyst
streptococcal screening
rapid strep test
depth perception assessment
sensory integration therapy
tape stripping procedure
sleep apnea treatment
fetal cell transplantation
transcranial magnetic stimulation
karyotyping
chromosomal microarray testing
targeted gene sequencing
single gene testing
gene panel testing
methylation testing
cell-free DNA testing
reproductive technology treatment
eye drop therapy
thalidomide agent therapy
complement component 5 inhibitor agent therapy
4-hydroxyphenylpyruvate dioxygenase inhibitor agent therapy
add mevalonolactone therapy
antimyopathic therapy
alpha-melanocyte stimulating hormone therapy
carbonic anhydrase inhibitor agent therapy
vmat2 inhibitor therapy
thalidomide avoidance recomendation
coagulation factor therapy
What's Changed
- Feature/maxoa2 by @iimpulse in #642
- Route of administration branch by @LCCarmody in #644
- add hearing aid use with FM amplification by @LCCarmody in #645
- Issue 331 denture by @LCCarmody in #646
- add dopamine replacement agent therapy by @LCCarmody in #647
- Prenatal terms by @LCCarmody in #648
- add monoamine-depleting agent therapy by @LCCarmody in #649
- add manganese chelator therapy #438 by @LCCarmody in #650
- add fluid restriction term #456 by @LCCarmody in #655
- added high fat diet intake. #476 by @LCCarmody in #656
- Add to intubation branch by @LCCarmody in #657
- mmunoglobulin infusion therapy #493 by @LCCarmody in #658
- Glaucoma treatment terms by @LCCarmody in #659
- Topical agent therapy by @LCCarmody in #660
- Surgery related issues by @LCCarmody in #661
- Eye therapies by @LCCarmody in #662
- Rnai and antisense by @LCCarmody in #663
- Medical history by @LCCarmody in #664
- removal of ovarian cyst by @LCCarmody in #665
- Include terms by @LCCarmody in #666
- added fetal cell transplantation close issue #653 by @LCCarmody in #667
- add TMS close #652 by @LCCarmody in #668
- Diagnostic genetic tests by @LCCarmody in #669
- cell-free DNA testing issue #623 by @LCCarmody in #670
- add reproductive technology treatment by @LCCarmody in #671
- Pharmacotherapy by @LCCarmody in #672
- add coagulation factor therapy #343 by @LCCarmody in #673
Full Changelog: v2024-05-24...v2024-07-29
May 24 2024 Release
May 2024 release
Updated the imports and CHEBI Slim to update all undefined terms.
Feb 2024 Release
Technical updates
- Fix super class graph errors.
- Update QC errors
- Add automated release of maxoa file (from POET)
Ontology updates
-
Update small errors in diagnostic hierarchy.
-
Fix issues with anti-HIV agent therapy logical def.
December 2023 release
Updated typos
Replaced
hematopoietic cell count was replaced by blood cell count
added release step for maxoa (MAxO annotations) from POET
Updated
MAXO:0000479 orthopedic surgery
MAXO:0000024 surgical procedure on the eye
MAXO:0000946 nervous system surgical procedure
MAXO:0000012 surgery by site
MAXO:0025005 nasolacrimal duct surgery
MAXO:0000424 magnetic resonance imaging
added
MAXO:0010131 tongue swab collection
MAXO:0001505 gross motor therapy
MAXO:0001516 fine motor therapy
MAXO:0001477 orchiopexy
MAXO:0001472 fundoplication
MAXO:0001395 radiofrequency ablation
MAXO:0001513 skin surgery
MAXO:0001503 digestive system surgery
MAXO:0001504 alimentary part of gastrointestinal system surgery
MAXO:0025001 cardiovascular system surgery
MAXO:0001506 circulatory system surgery
MAXO:0001507 musculoskeletal system
MAXO:0001508 genitourinary system surgery
MAXO:0001510 pancreatic system surgery
MAXO:0001511 renal collecting system surgery
MAXO:0001512 reproductive system surgery
MAXO:0001514 vascular system surgery
MAXO:0001515 skeletal system surgery
October 2023 Release
October 2023 Release
Technical changes
-
Update ODK to 1.4.3
-
Update FOODON imports
-
Update DOSDP files
Curation updates
Several minor updates have been made and a few terms. The only major change is that that created_by label was updated to dcterms:creator to be more consistent with OBO ontologies.
Changed or added
- Make preventive therapy singular
- Add adrenal hormone replacement therapy
- add adrenal hormone stimulating therapy
- add adrenal hormone suppressant therapy
- add prodrug therapy
- add neuroprotective agent therapy
- add orphan drug therapy
- add hppd inhibitor therapy
- add tyrosine metabolism inhibitor therapy
June 2023 Release
Adding ROBOT terms
MAXO ID | MAXO label |
---|---|
MAXO:0035121 | electrooculogram procedure |
MAXO:0035120 | cardiac auscultation |
MAXO:0035119 | duplex ultrasound with color flow imaging |
MAXO:0035118 | cardiac catheterization |
MAXO:0035115 | diffusion weighted cerebral MRI |
MAXO:0035114 | immune cell function assay |
MAXO:0035113 | platelet transmission electron microscopy |
MAXO:0035054 | protein glycosylation assay |
MAXO:0035110 | gustatory testing |
MAXO:0035109 | immune complex assay |
MAXO:0035108 | sweat electrolyte test |
MAXO:0035106 | paracentesis |
MAXO:0035105 | salivary cortisol test |
MAXO:0035104 | motor evoked potential evaluation |
MAXO:0035103 | refraction test |
MAXO:0035102 | water deprivation test |
MAXO:0035101 | phrenic nerve stimulation test |
MAXO:0035099 | electroretinogram procedure |
MAXO:0035096 | breath hydrogen test |
MAXO:0035094 | platelet aggregation assay |
MAXO:0035093 | erythrocyte sedimentation rate measurement |
MAXO:0035092 | fractional excretion assessment |
MAXO:0035091 | electromyography procedure |
MAXO:0035084 | fructose tolerance test |
MAXO:0035083 | CT urogram |
MAXO:0035080 | apoptosis assay |
MAXO:0035079 | neonatologist evaluation |
MAXO:0035078 | pulmonary function testing |
MAXO:0035077 | functional T cell assessment |
MAXO:0035076 | complement assay |
MAXO:0035068 | natural killer cell function test |
MAXO:0035067 | perchlorate discharge test |
MAXO:0035066 | somatosensory evoked potential assessment |
MAXO:0035065 | dentist evaluation |
MAXO:0035064 | electron microscopic study |
MAXO:0035063 | jerk-locked averaging |
MAXO:0035058 | hormone measurement |
MAXO:0035062 | urine hormone measurement |
MAXO:0035059 | nerve conduction study |
MAXO:0035057 | reproductive endocrinologist assessment |
MAXO:0035055 | flow cytometry procedure |
MAXO:0035040 | abdominal paracentesis |
MAXO:0035025 | in vitro DNA repair study |
MAXO:0035028 | L-selectin shedding study |
MAXO:0035036 | blood culture procedure |
MAXO:0035017 | hair microscopy |
MAXO:0035005 | circulating hormone measurement |
MAXO:0035027 | blood gas assessment in umbilical cord blood |
MAXO:0035011 | enzyme activity assessment |
MAXO:0035026 | circulating immunoglobulin measurement |
MAXO:0035029 | cerebrospinal fluid metabolite measurement |
MAXO:0035019 | erythrocyte enzyme activity assessment |
MAXO:0035018 | leukocyte enzyme activity assessment |
MAXO:0035020 | tissue enzyme activity assessment |
MAXO:0035047 | stool metabolite measurement |
MAXO:0035031 | stool xenobiotic measurement |
MAXO:0035023 | tissue metabolite measurement |
MAXO:0035032 | gastric fluid xenobiotic measurement |
MAXO:0035033 | hair xenobiotic measurement |
MAXO:0035117 | cardiac exercise stress test |
MAXO:0035090 | hepatobiliary iminodiacetic acid scan |
MAXO:0035097 | visual evoked potential procedure |
MAXO:0035075 | sperm analysis |
MAXO:0035069 | dysmorphology assessment |
MAXO:0035024 | high-resolution pulmonary computed tomography |
MAXO:0035030 | gastrointestinal transit measurement |
MAXO:0035046 | esophageal manometry |
MAXO:0035060 | central motor conduction time study |
MAXO:0035007 | cerebrospinal fluid analysis |
MAXO:0035009 | examination by dentist |
MAXO:0035010 | examination by neonatologist |
MAXO:0035012 | perimetry examination |
MAXO:0035015 | visual acuity assessment |
MAXO:0035041 | neurodevelopmental assessment |
MAXO:0035122 | cell function assay |
MAXO:0001478 | fetal MRI |
MAXO:0001479 | allogeneic hematopoietic stem cell transplantation |
MAXO:0001480 | immunoglobulin infusion therapy |
MAXO:0001481 | IgE-targeting biologic therapy |
MAXO:0001482 | Th2-targeting biologic therapy |
MAXO:0001483 | complement 5 inhibitor therapy |
MAXO:0001484 | gene editing therapy |
MAXO:0001485 | glutamine supplementation |
MAXO:0001486 | interferon alpha therapy |
MAXO:0001487 | interferon-gamma therapy |
MAXO:0001488 | interleukin-1 receptor inhibitor therapy |
MAXO:0001489 | live vaccine avoidance |
MAXO:0001490 | platelet transfusion |
MAXO:0001491 | somatostatin analog therapy |
MAXO:0001492 | surveillance for malignancies |
MAXO:0001493 | tumor necrosis factor inhibitor therapy |
MAXO:0001494 | ophthalmological diagnostic procedure |
MAXO:0035021 | iron-binding capacity assessment |
MAXO:0035123 | viral cell culture |
MAXO:0001496 | serotonin-norepinephrine reuptake inhibitor agent therapy avoidance |
May 17 2023 Release
Forgot to run the official release suggested on the previous day.
This release pushes all the info from May 16
May 16 2023 release
New pharmacotherapy terms added
MAxO ID | MAxO label |
---|---|
MAXO:0001469 | farnesyltransferase inhibitor agent therapy |
MAXO:0001470 | MMP inhibitor agent therapy |
MAXO:0001474 | thyroid hormone therapy |
MAXO:0001475 | sodium-glucose cotransporter-2 inhibitor therapy |
MAXO:0001476 | somatostatin recepter agonist therapy |
MAXO:0001473 | benzothiadiazine derivative therapy |
MAXO:0001471 | tazarotene agent therapy |
May 2023 release
Quick release to fix a space in IRI
April 2023 release #2
Finishing up Maxolyzer terms
MAXO:0035024 | high-resolution pulmonary computed tomography
MAXO:0035030 | gastrointestinal transit measurement
MAXO:0035046 | esophageal manometry
MAXO:0035060 | central motor conduction time study
MAXO:0035007 | cerebrospinal fluid analysis
MAXO:0035009 | examination by dentist
MAXO:0035010 | examination by neonatologist
MAXO:0035012 | perimetry examination
MAXO:0035015 | visual acuity assessment
MAXO:0035016 | optical coherence tomography
MAXO:0035041 | neurodevelopmental assessment
MAXO:0035100 | applanation tonometry
MAXO:0035122 | cell function assay
MAXO:0035037 | gastroscopy
MAXO:0035042 | duodenoscopy
MAXO:0035044 | cardiac CT
MAXO:0035052 | hip radiography